Merck

Merck Joins with HAPPYneuron to Add Cognitive Training Games to MSdialog

Merck Biopharma Ā announced it has entered intoĀ aĀ partnership with a French subsidiary calledĀ HAPPYneuron,Ā and now hasĀ an exclusive license to that companyā€™s cognitiveĀ remediation training program for multiple sclerosis (MS).Ā The program, a series of brain training games and exercises, will be made available to people needing itĀ throughĀ Merck’s MSdialog platform. An e-Health…

Merck Prepares to File for European Marketing Authorization for Cladribine Tablets as a Multiple Sclerosis Therapy

MerckĀ recently reported its intention to file for European registration of its product candidate forĀ relapsing multiple sclerosis – Cladribine, a synthetic anti-cancer agent able to suppress the immune system. Cladribine causesĀ relatively few side effects and results in very little non-target cell loss. Merck’s decision follows new findingsĀ and further characterization of…